Speaker illustration

Doctor Jose Anselmo Coelho Lima Junior

Addenbrooke’s Hospital, Cambridge (United Kingdom of Great Britain & Northern Ireland)

Dr Coelho-Lima is a PhD candidate in molecular cardiology at Newcastle University (UK) and a foundation trainee doctor at the Royal Stoke University Hospital (UK). His research focuses on the discovery and validation of circulating biomarkers for risk stratification of patients with ST-elevation myocardial infarction.

miR-1 and miR-133b are associated with failed myocardial reperfusion and worse left ventricular functional recovery in STEMI patients

Event: EuroPrevent 2019

Topic: Secondary Prevention

Session: Moderated Posters Session 3

Thumbnail

Admission cardiac troponin T improves risk stratification of patients with ST elevation myocardial infarction

Event: EuroPrevent 2019

Topic: Secondary Prevention

Session: Risk Factors and Prevention - Secondary Prevention

Thumbnail

Pre-procedural cardiac troponin, but not peak troponin, is a predictor of outcome in patients with ST elevation myocardial infarction undergoing PPCI

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Cardiac troponins: starting levels and outcomes

Thumbnail

Release kinetics of muscle-enriched microRNAs during primary PCI predict coronary microvascular obstruction and suggest the nonexistence of reperfusion injury in human patients

Event: ESC Congress 2017

Topic: Infarction acute phase STEMI

Session: Best Posters in new insight in STEMI pathophysiology

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb